Assessing efficacy of New FP (a combination of 50 mg fine powder formulation of Cisplatin in 5‐10 ml lipiodol and contimuous infusion of 5‐fluorouracil (1,500 mg/5 days) in patients with BCLC stage C hepatocellular carcinoma
Latest Information Update: 21 Feb 2020
At a glance
- Drugs Cisplatin (Primary) ; Ethiodized oil (Primary) ; Fluorouracil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 21 Feb 2020 New trial record